Starling Oncology, Inc. Financing Cash Flow
Starling Oncology, Inc. (STLN) reported Financing Cash Flow of -$246.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- Starling Oncology, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$218.00K, a 111.11% decline year-over-year.
- Starling Oncology, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$28.00K.
- Starling Oncology, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $3.73M.
- Starling Oncology, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $10.60M.
- Starling Oncology, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $11.56M.
- Starling Oncology, Inc. net cash provided by (used in) financing activities for fiscal 2024 was -$3.49M.
- Starling Oncology, Inc. net cash provided by (used in) financing activities for fiscal 2023 was -$6.85M, a 107.43% decline from fiscal 2022.
- Starling Oncology, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $92.21M, a 40.13% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 2 month | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$218.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$246.00K 10-Q · filed 2026-08-06 | $3.49M derived: sum of 3 quarters · filed 2026-08-06 | $14.09M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$28.00K 10-Q · filed 2026-05-07 | $3.71M derived: sum of 2 quarters · filed 2026-05-07 | $14.31M derived: sum of 3 quarters · filed 2026-05-07 | $16.27M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $3.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $14.33M derived: sum of 2 quarters · filed 2026-03-12 | $16.30M derived: sum of 3 quarters · filed 2026-08-06 | $11.56M 10-K · filed 2026-03-12 | ||
| 2025-09-30 | $10.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $12.56M derived: sum of 2 quarters · filed 2026-08-06 | $7.82M 10-Q · filed 2025-11-13 | $7.66M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $1.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.78M 10-Q · filed 2026-08-06 | -$2.94M derived: sum of 3 quarters · filed 2026-08-06 | -$3.18M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | -$4.74M 10-Q · filed 2026-05-07 | -$4.90M derived: sum of 2 quarters · filed 2026-05-07 | -$5.15M derived: sum of 3 quarters · filed 2026-05-07 | -$7.29M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | -$164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$407.00K derived: sum of 2 quarters · filed 2026-03-12 | -$2.55M derived: sum of 3 quarters · filed 2026-03-12 | -$3.49M 10-K · filed 2026-03-12 | ||
| 2024-09-30 | -$243.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$2.39M derived: sum of 2 quarters · filed 2025-11-13 | -$3.33M 10-Q · filed 2025-11-13 | -$5.11M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | -$2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$3.08M 10-Q · filed 2025-08-13 | -$4.87M derived: sum of 3 quarters · filed 2025-08-13 | -$5.62M derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | -$938.00K 10-Q · filed 2025-05-14 | -$2.72M derived: sum of 2 quarters · filed 2025-05-14 | -$3.48M derived: sum of 3 quarters · filed 2025-05-14 | -$6.08M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | -$1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$2.54M derived: sum of 2 quarters · filed 2025-03-26 | -$5.14M derived: sum of 3 quarters · filed 2025-03-26 | -$6.85M 10-K · filed 2025-03-26 | ||
| 2023-09-30 | -$756.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$3.36M derived: sum of 2 quarters · filed 2024-11-13 | -$5.07M 10-Q · filed 2024-11-13 | -$5.91M derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | -$2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$4.31M 10-Q · filed 2024-08-13 | -$5.16M derived: sum of 3 quarters · filed 2024-08-13 | $100.24M derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | -$1.71M 10-Q · filed 2024-05-14 | -$2.56M derived: sum of 2 quarters · filed 2024-05-14 | $102.84M derived: sum of 3 quarters · filed 2024-05-14 | $92.15M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | -$847.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $104.55M derived: sum of 2 quarters · filed 2024-03-28 | $93.86M derived: sum of 3 quarters · filed 2024-03-28 | $92.21M 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $105.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $94.71M derived: sum of 2 quarters · filed 2023-11-08 | $93.05M 10-Q · filed 2023-11-08 | $229.18M derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2022-06-30 | -$10.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$12.34M 10-Q · filed 2023-08-09 | $123.79M derived: sum of 3 quarters · filed 2023-08-09 | $123.78M derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | -$1.66M 10-Q · filed 2023-05-10 | $134.47M derived: sum of 2 quarters · filed 2023-05-10 | $134.46M derived: sum of 3 quarters · filed 2023-05-10 | $129.96M derived: sum of 4 quarters · filed 2023-05-10 | ||
| 2021-12-31 | $136.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $136.12M derived: sum of 2 quarters · filed 2023-03-16 | $131.61M derived: sum of 3 quarters · filed 2023-03-16 | $154.01M 10-K · filed 2023-03-16 | ||
| 2021-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$4.51M derived: sum of 2 quarters · filed 2022-11-09 | $17.88M 10-Q · filed 2022-11-09 | -$201.70M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | -$4.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $17.89M 10-Q · filed 2022-08-09 | -$201.70M derived: sum of 3 quarters · filed 2022-08-09 | -$201.73M derived: sum of 4 quarters · filed 2022-08-09 | ||
| 2021-03-31 | $22.40M 10-Q · filed 2022-05-10 | -$197.19M derived: sum of 2 quarters · filed 2022-05-10 | -$197.23M derived: sum of 3 quarters · filed 2022-05-10 | -$197.23M derived: sum of 4 quarters · filed 2022-05-10 | ||
| 2020-12-31 | -$219.59M derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-11 | -$219.62M derived: sum of 2 quarters · filed 2022-03-11 | -$219.62M derived: sum of 3 quarters · filed 2022-03-11 | $11.89M 10-K · filed 2022-03-11 | $231.47M 10-K · filed 2021-03-30 | |
| 2020-09-30 | -$35.12K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2021-12-14 | -$36.67K derived: sum of 2 quarters · filed 2021-12-14 | $231.47M 10-Q/A · filed 2021-12-14 | |||
| 2020-06-30 | -$1.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $231.51M 10-Q · filed 2021-08-16 | ||||
| 2020-03-31 | $231.51M 10-Q · filed 2021-05-28 | |||||
| 2019-12-31 | $25.00K 10-K/A · filed 2021-12-14 |